FDA
-
-
Highlights from FDA Meetings on 3 Opioid-Related New Drug Applications
Read more: Highlights from FDA Meetings on 3 Opioid-Related New Drug Applications -
Addiction Daniel Aaron FDA Health Law Policy Market Design Mental Health Pediatrics Personal Responsibility Public Health Scientific Evidence Social Determinants of Health Student Fellows TobaccoE-Cigarette Laws that Work for Everyone
Read more: E-Cigarette Laws that Work for Everyone -
New HarvardX Course on the FDA and Prescription Drugs
Read more: New HarvardX Course on the FDA and Prescription Drugs -
The Cry Over Fake Milk
Read more: The Cry Over Fake Milk -
Meditation? There’s an (almost FDA-approved) app for that
Read more: Meditation? There’s an (almost FDA-approved) app for that -
Wishes at the end of life: comparing the right to try and right to die
Read more: Wishes at the end of life: comparing the right to try and right to die -
Bioethics Clinical Research FDA Health Law Policy Mason Marks Medical Safety Mental Health Pain Pharmaceuticals Public Health Scientific Evidence
Simulated Side Effects: FDA Uses Novel Computer Model to Guide Kratom Policy
Read more: Simulated Side Effects: FDA Uses Novel Computer Model to Guide Kratom Policy -
Innovation Gaps on Life Science Frontiers
Read more: Innovation Gaps on Life Science Frontiers -
Bioethics Biotechnology Cloning Enhancement FDA Genetics Health Law Policy Human Rights Human Tissue Intellectual Property Neuroscience Organs Pharmaceuticals Research Funding Stem Cells Timo Minssen
Patenting Bioprinting Technologies in the US and Europe – The Fifth Element in the Third Dimension
Read more: Patenting Bioprinting Technologies in the US and Europe – The Fifth Element in the Third Dimension